[{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"181840"},{"sessionId":"11045","sessionTitle":"Bone Marrow Failure: Inherited","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"181840"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"198574"},{"sessionId":"11046","sessionTitle":"Bone Marrow Failure: Acquired","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"198574"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"194200"},{"sessionId":"11047","sessionTitle":"Management of Sickle Cell Disease: Present and Future","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"194200"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"500745"},{"sessionId":"11048","sessionTitle":"Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"500745"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"32048"},{"sessionId":"11049","sessionTitle":"Emerging Issues in Clinical Care in Thalassemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"32048"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"554684"},{"sessionId":"11050","sessionTitle":"Congenital and Acquired Neutropenia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"554684"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562608"},{"sessionId":"11051","sessionTitle":"Therapeutic Apheresis as an Immunomodulatory Tool","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562608"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"551831"},{"sessionId":"11052","sessionTitle":"The Changing Landscape of Hemophilia Therapy","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"551831"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"532477"},{"sessionId":"11053","sessionTitle":"Controversies in Venous Thromboembolism: To Treat or Not to Treat","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"532477"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"259455"},{"sessionId":"11054","sessionTitle":"Common Clinical Questions in Cancer-Associated Venous Thromboembolism","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"259455"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"534"},{"sessionId":"11055","sessionTitle":"Common Hematologic Consults in Pregnancy","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"534"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"170285"},{"sessionId":"11056","sessionTitle":"Thrombocytopenia in Hospitalized Patients","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"170285"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"501625"},{"sessionId":"11057","sessionTitle":"Thrombosis, Devices, and Interventions","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"501625"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"527896"},{"sessionId":"11058","sessionTitle":"It All Starts Here: Disorders of Primary Hemostasis","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"527896"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"197815"},{"sessionId":"11059","sessionTitle":"Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"197815"},{"sessionId":"11060","sessionTitle":"Emerging Pathogens from A to Zika and Their Impact on Transfusion Safety","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"160562"},{"sessionId":"11061","sessionTitle":"A Sticky Business: New Insights Into Neutrophil Extracellular Traps (NETs) in Physiology and Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"566646"},{"sessionId":"11062","sessionTitle":"Debate: Patients With Acquired TTP in Remission Should Be Treated to Prevent Relapse","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"259282"},{"sessionId":"11063","sessionTitle":"Getting Patients to Transplant: Myths and Reality","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"213032"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"259122"},{"sessionId":"11064","sessionTitle":"Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"259122"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"221969"},{"sessionId":"11065","sessionTitle":"Primary Immunodeficiencies From Childhood to Adulthood","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"221969"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562540"},{"sessionId":"11066","sessionTitle":"Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562540"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562541"},{"sessionId":"11067","sessionTitle":"Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562541"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"225270"},{"sessionId":"11068","sessionTitle":"Hematopoietic Stem Cell Generation: Reprogramming and Expansion","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"225270"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"556004"},{"sessionId":"11069","sessionTitle":"Impact of the Contact Pathway on Disease States: Molecular Mechanisms","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"556004"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"190859"},{"sessionId":"11070","sessionTitle":"New Approaches to Understanding Microbial Immune System Interactions","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"190859"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"193732"},{"sessionId":"11071","sessionTitle":"Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"193732"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"501235"},{"sessionId":"11072","sessionTitle":"Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"501235"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"531606"},{"sessionId":"11073","sessionTitle":"New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"531606"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"155722"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"155722"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"156533"},{"sessionId":"11074","sessionTitle":"Clonal Evolution in Myeloid Malignancies","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"156533"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"148865"},{"sessionId":"11075","sessionTitle":"The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"148865"},{"sessionId":"11077","sessionTitle":"Presidential Symposium","sessionStartTime":"9:45:00 AM","sessionEndTime":"11:15:00 AM","sessionPerson":"574592"},{"sessionId":"11078","sessionTitle":"ASH-EHA Joint Symposium","sessionStartTime":"12:30:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"574592"},{"sessionId":"11078","sessionTitle":"ASH-EHA Joint Symposium","sessionStartTime":"12:30:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"148939"},{"sessionId":"11081","sessionTitle":"ASH Practice Partnership Lunch","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:30:00 PM","sessionPerson":"206"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562542"},{"sessionId":"11083","sessionTitle":"Special Symposium on Quality","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"212370"},{"sessionId":"11084","sessionTitle":"ASH Choosing Wisely® Campaign: 2017 ASH Choosing Wisely Champions","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"228952"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533488"},{"sessionId":"11085","sessionTitle":"Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562543"},{"sessionId":"11086","sessionTitle":"Quality Conversations on Social Media: Achieving Credibility and Efficiency Together","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"8764"},{"sessionId":"11087","sessionTitle":"AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"565783"},{"sessionId":"11088","sessionTitle":"Global Hematology Symposium","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"501004"},{"sessionId":"11088","sessionTitle":"Global Hematology Symposium","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"601296"},{"sessionId":"11089","sessionTitle":"Blood and Beyond: The Art of Perception","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"199045"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"161247"},{"sessionId":"11090","sessionTitle":"When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"161247"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562478"},{"sessionId":"11091","sessionTitle":"Dilemmas in Pediatric Hematologic Malignancy","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562478"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"561939"},{"sessionId":"11092","sessionTitle":"Novel Therapeutics in Myeloma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561939"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"574399"},{"sessionId":"11093","sessionTitle":"Controversies in Myeloma","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"574399"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"259407"},{"sessionId":"11094","sessionTitle":"Myelodysplastic Syndromes: Understanding the Current Treatment Landscape","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"259407"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"221542"},{"sessionId":"11095","sessionTitle":"Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"221542"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561820"},{"sessionId":"11096","sessionTitle":"Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"561820"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"575290"},{"sessionId":"11097","sessionTitle":"Acute Lymphocytic Leukemia: New Approaches in Management","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"575290"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon “Standard” Therapy?","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"198350"},{"sessionId":"11098","sessionTitle":"Acute Myeloid Leukemia: How Can We Improve Upon “Standard” Therapy?","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"198350"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561667"},{"sessionId":"11099","sessionTitle":"Individualizing Therapy in Chronic Lymphocytic Leukemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561667"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"260007"},{"sessionId":"11100","sessionTitle":"The Challenge of Primary and Secondary Central Nervous System Lymphoma","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"260007"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"260008"},{"sessionId":"11101","sessionTitle":"The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"260008"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"196488"},{"sessionId":"11102","sessionTitle":"Evolving Strategies in Aggressive B-Cell Lymphoma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"196488"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"536769"},{"sessionId":"11103","sessionTitle":"Hodgkin Lymphoma: New Insights and New Approaches","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"536769"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"537512"},{"sessionId":"11104","sessionTitle":"Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"537512"},{"sessionId":"11105","sessionTitle":"Identification and Management of Toxicities Induced by Immunotherapies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"547329"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562272"},{"sessionId":"11106","sessionTitle":"Editing and Enhancing Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562272"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"177189"},{"sessionId":"11107","sessionTitle":"Evolving Approaches to Gene Therapy for Blood Diseases","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"177189"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"259244"},{"sessionId":"11108","sessionTitle":"Thrombosis: A View From the World of Bioengineering","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"259244"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562544"},{"sessionId":"11109","sessionTitle":"Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562544"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562545"},{"sessionId":"11110","sessionTitle":"Targeting T-Cell Exhaustion","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562545"},{"sessionId":"11111","sessionTitle":"Special Scientific Symposium on Targeted Therapy: What Is the Best Target?","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"534128"},{"sessionId":"11112","sessionTitle":"Special Scientific Symposium on Understanding and Modulating the DNA Damage Response","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"518134"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:30:00 PM","sessionPerson":"556004"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:30:00 PM","sessionPerson":"531606"},{"sessionId":"11113","sessionTitle":"Special Symposium on the Basic Science of Hemostasis and Thrombosis","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:30:00 PM","sessionPerson":"259244"},{"sessionId":"11114","sessionTitle":"Special Scientific Symposium on Hot Topics in Hematology: New Pathways Linking Hematopoiesis, Thrombosis, and Cardiovascular Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"8753"},{"sessionId":"11115","sessionTitle":"The Impact of the Microbiome on the Hematologic System: Thrombosis and Graft-Versus-Host Disease","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"258849"},{"sessionId":"11116","sessionTitle":"Beyond Sequencing: Emerging Tools for Analysis of Multi-Omic Genomic Data in Acquired and Inherited Hematologic Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562312"},{"sessionId":"11139","sessionTitle":"Trainee Day Didactic Session 1: Statistics and Trial Design","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"501294"},{"sessionId":"11159","sessionTitle":"Trainee Didactic Session: Time Management and Balance","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"518724"},{"sessionId":"11166","sessionTitle":"K2R: Breakout 1: Basic Science","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"53371"},{"sessionId":"11166","sessionTitle":"K2R: Breakout 1: Basic Science","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"537491"},{"sessionId":"11166","sessionTitle":"K2R: Breakout 1: Basic Science","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"562033"},{"sessionId":"11168","sessionTitle":"K2R: Breakout 2: Clinical","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"279802"},{"sessionId":"11168","sessionTitle":"K2R: Breakout 2: Clinical","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"547329"},{"sessionId":"11169","sessionTitle":"K2R: Breakout 3: Education/ Epidemiology/ Health Services","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"534425"},{"sessionId":"11169","sessionTitle":"K2R: Breakout 3: Education/ Epidemiology/ Health Services","sessionStartTime":"2:30:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"158654"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"537491"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"562033"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"279802"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"547329"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"534425"},{"sessionId":"11170","sessionTitle":"K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"158654"},{"sessionId":"11177","sessionTitle":"Hematology Course Directors’ Workshop","sessionStartTime":"7:00:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"536178"},{"sessionId":"11178","sessionTitle":"Junior Faculty Development  Education Session: Grant Funding: How to Get It and How to Keep It Going","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"259804"},{"sessionId":"11181","sessionTitle":"Career Development Lunch Sessions: Room 1","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"534308"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"537238"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"540460"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"540460"},{"sessionId":"11217","sessionTitle":"Networking Reception for Female Hematologists","sessionStartTime":"7:30:00 PM","sessionEndTime":"9:00:00 PM","sessionPerson":"537238"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"574592"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"534434"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"507021"},{"sessionId":"11220","sessionTitle":"Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal","sessionStartTime":"9:30:00 AM","sessionEndTime":"9:45:00 AM","sessionPerson":"562222"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"574592"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"3247"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"209779"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"561438"},{"sessionId":"11224","sessionTitle":"Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology","sessionStartTime":"1:30:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"4491"},{"sessionId":"11231","sessionTitle":"Training Program Directors’ Workshop","sessionStartTime":"12:00:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"501609"},{"sessionId":"11243","sessionTitle":"How to Get Published in a Peer-Reviewed Journal","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"555042"},{"sessionId":"11245","sessionTitle":"Meet the Blood Editors","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"542268"},{"sessionId":"11245","sessionTitle":"Meet the Blood Editors","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"538593"},{"sessionId":"11246","sessionTitle":"Meet the Blood Editors","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"134390"},{"sessionId":"11246","sessionTitle":"Meet the Blood Editors","sessionStartTime":"12:15:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"531724"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","sessionStartTime":"7:00:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"198162"},{"sessionId":"11316","sessionTitle":"Consultative Hematology Course","sessionStartTime":"7:00:00 AM","sessionEndTime":"11:30:00 AM","sessionPerson":"3509"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259122"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"204570"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562710"},{"sessionId":"11338","sessionTitle":"Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562839"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"155722"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"156533"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"562715"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"193779"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"561656"},{"sessionId":"11339","sessionTitle":"Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies","sessionStartTime":"11:45:00 AM","sessionEndTime":"12:45:00 PM","sessionPerson":"562652"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"501235"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562649"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562650"},{"sessionId":"11341","sessionTitle":"Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259560"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"531606"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259101"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"130745"},{"sessionId":"11344","sessionTitle":"Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"259103"},{"sessionId":"11346","sessionTitle":"Plasma Cells and Myeloma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"501405"},{"sessionId":"11347","sessionTitle":"Platelet Clearance","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"205242"},{"sessionId":"11349","sessionTitle":"Contact Pathways in Health and Disease","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"500752"},{"sessionId":"11351","sessionTitle":"Next Generation Sequencing as a Diagnostic Tool for Precision Medicine","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"504622"},{"sessionId":"11354","sessionTitle":"The Role of Genetic Pathways in Bone Marrow Failure","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562125"},{"sessionId":"11355","sessionTitle":"How Long to Anticoagulate My Patient With VTE","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"532477"},{"sessionId":"11357","sessionTitle":"Immune Thrombocytopenia","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"22321"},{"sessionId":"11358","sessionTitle":"Thrombotic Thrombocytopenic Purpura","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562615"},{"sessionId":"11359","sessionTitle":"Aplastic Anemia","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562176"},{"sessionId":"11360","sessionTitle":"ALL in Adolescents and Young Adults","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"575290"},{"sessionId":"11361","sessionTitle":"Individualized Therapy in Patients With AML","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"198350"},{"sessionId":"11362","sessionTitle":"Treating and Monitoring Patients With CML","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"561820"},{"sessionId":"11363","sessionTitle":"Novel Therapy Combinations in Multiple Myeloma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"207904"},{"sessionId":"11364","sessionTitle":"Relapsed/Refractory Diffuse Large B-Cell Lymphoma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"575112"},{"sessionId":"11378","sessionTitle":"Heparin-Induced Thrombocytopenia: HITs and Misses","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"170285"},{"sessionId":"11379","sessionTitle":"Tailored Therapy for Patients With Hodgkin Lymphoma","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"260008"},{"sessionId":"11394","sessionTitle":"Platelet Regulation of Tumor Growth and Metastasis","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"520889"},{"sessionId":"11395","sessionTitle":"Reversal of Anticoagulants","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"501589"},{"sessionId":"11397","sessionTitle":"Hematopoietic Stem Cell Generation, Reprogramming, and Expansion","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"153294"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"532359"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"8622"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"8622"},{"sessionId":"11399","sessionTitle":"Best of ASH","sessionStartTime":"11:30:00 AM","sessionEndTime":"1:00:00 PM","sessionPerson":"532359"},{"sessionId":"11400","sessionTitle":"Genome Sequencing in the Newborn: Diagnostic Challenges and Emerging Opportunities","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562727"},{"sessionId":"11401","sessionTitle":"Understanding Microbial Immune System Interactions","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"562643"},{"sessionId":"11405","sessionTitle":"Scholarly Work in Quality Improvement","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"525107"},{"sessionId":"11405","sessionTitle":"Scholarly Work in Quality Improvement","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"228952"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"593569"},{"sessionId":"11475","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562063"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"112529"},{"sessionId":"11476","sessionTitle":"101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561891"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"477980"},{"sessionId":"11477","sessionTitle":"102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"565717"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"56480"},{"sessionId":"11478","sessionTitle":"102. Regulation of Iron Metabolism: Iron and erythropoiesis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"42577"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562031"},{"sessionId":"11479","sessionTitle":"112. Thalassemia and Globin Gene Regulation I","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"560737"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562029"},{"sessionId":"11480","sessionTitle":"112. Thalassemia and Globin Gene Regulation II","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"1451"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Hematopoiesis and Fetal Hemoglobin Augmentation","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"600383"},{"sessionId":"11481","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Hematopoiesis and Fetal Hemoglobin Augmentation","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"263951"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Pathophysiology and Investigational Therapies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"525657"},{"sessionId":"11482","sessionTitle":"113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Pathophysiology and Investigational Therapies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"238542"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical I","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"585711"},{"sessionId":"11483","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical I","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"127120"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical II","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"498152"},{"sessionId":"11484","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical II","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"533775"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical III","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"572066"},{"sessionId":"11485","sessionTitle":"114. Hemoglobinopathies, Excluding Thalassemia—Clinical III","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"566821"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561743"},{"sessionId":"11486","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages: SCN","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562241"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561656"},{"sessionId":"11487","sessionTitle":"201. Granulocytes, Monocytes, and Macrophages I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"553989"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562100"},{"sessionId":"11488","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"94589"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561804"},{"sessionId":"11489","sessionTitle":"203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562401"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"570382"},{"sessionId":"11490","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562169"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"4899"},{"sessionId":"11491","sessionTitle":"301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"533887"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561807"},{"sessionId":"11492","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: clinical aspects","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533871"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"561917"},{"sessionId":"11493","sessionTitle":"311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"575232"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"560783"},{"sessionId":"11494","sessionTitle":"311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562109"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"561934"},{"sessionId":"11495","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"500678"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562224"},{"sessionId":"11496","sessionTitle":"321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"577026"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562373"},{"sessionId":"11497","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"574857"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"501239"},{"sessionId":"11498","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"513207"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562108"},{"sessionId":"11499","sessionTitle":"322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"53915"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533415"},{"sessionId":"11500","sessionTitle":"331. Pathophysiology of Thrombosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"565657"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"481091"},{"sessionId":"11501","sessionTitle":"331. Pathophysiology of Thrombosis II","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562211"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"587218"},{"sessionId":"11502","sessionTitle":"332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562361"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562816"},{"sessionId":"11503","sessionTitle":"332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561945"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"63632"},{"sessionId":"11504","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562008"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"8447"},{"sessionId":"11505","sessionTitle":"401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562047"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"523139"},{"sessionId":"11506","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562329"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"597643"},{"sessionId":"11507","sessionTitle":"501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561720"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"555336"},{"sessionId":"11508","sessionTitle":"502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"198260"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562323"},{"sessionId":"11509","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"601171"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"561870"},{"sessionId":"11510","sessionTitle":"506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562013"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"544458"},{"sessionId":"11511","sessionTitle":"508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"556082"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562926"},{"sessionId":"11512","sessionTitle":"508. Bone Marrow Failure: Biology and Therapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562284"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"533534"},{"sessionId":"11513","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"534128"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"532496"},{"sessionId":"11514","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"592809"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562918"},{"sessionId":"11515","sessionTitle":"602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"26657"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"223998"},{"sessionId":"11516","sessionTitle":"603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"500970"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"593552"},{"sessionId":"11517","sessionTitle":"603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533907"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562196"},{"sessionId":"11518","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562079"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562327"},{"sessionId":"11519","sessionTitle":"604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"250386"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: ALL and T-cell malignancies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"582644"},{"sessionId":"11520","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: ALL and T-cell malignancies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"501235"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"500736"},{"sessionId":"11521","sessionTitle":"605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561667"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"1750"},{"sessionId":"11522","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"542664"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"576033"},{"sessionId":"11523","sessionTitle":"612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"562000"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561782"},{"sessionId":"11524","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562231"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"497792"},{"sessionId":"11525","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"587400"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"567659"},{"sessionId":"11526","sessionTitle":"613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562191"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533906"},{"sessionId":"11527","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"546316"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562478"},{"sessionId":"11528","sessionTitle":"614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"544429"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"533917"},{"sessionId":"11529","sessionTitle":"615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"529931"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561798"},{"sessionId":"11530","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"538456"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"561860"},{"sessionId":"11531","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"561867"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561792"},{"sessionId":"11532","sessionTitle":"616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"563907"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562154"},{"sessionId":"11533","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"570637"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562156"},{"sessionId":"11534","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"553799"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"596905"},{"sessionId":"11535","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562119"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"584814"},{"sessionId":"11536","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533954"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"501235"},{"sessionId":"11537","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"498250"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533644"},{"sessionId":"11538","sessionTitle":"618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562267"},{"sessionId":"11539","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"582494"},{"sessionId":"11539","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"523342"},{"sessionId":"11540","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"489206"},{"sessionId":"11540","sessionTitle":"621. Lymphoma—Genetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"587130"},{"sessionId":"11541","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561708"},{"sessionId":"11541","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"535360"},{"sessionId":"11542","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562027"},{"sessionId":"11542","sessionTitle":"622. Lymphoma Biology—Non-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"575294"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Follicular Lymphoma, First Line","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561929"},{"sessionId":"11543","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Follicular Lymphoma, First Line","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"270930"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma, New Therapies","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"566029"},{"sessionId":"11544","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma, New Therapies","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562072"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"564847"},{"sessionId":"11545","sessionTitle":"623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"534057"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma—Chemotherapy and PET Studies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"501609"},{"sessionId":"11546","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma—Chemotherapy and PET Studies","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"572269"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561787"},{"sessionId":"11547","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"500849"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: T-Cell Lymphoma Clinical Studies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"575042"},{"sessionId":"11548","sessionTitle":"624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: T-Cell Lymphoma Clinical Studies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561734"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"86689"},{"sessionId":"11549","sessionTitle":"625.  Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"182391"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"494601"},{"sessionId":"11550","sessionTitle":"625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"535029"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561705"},{"sessionId":"11551","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"100460"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"595406"},{"sessionId":"11552","sessionTitle":"626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562077"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"534485"},{"sessionId":"11553","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562423"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"506719"},{"sessionId":"11554","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"596630"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"101324"},{"sessionId":"11555","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"274217"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"101324"},{"sessionId":"11556","sessionTitle":"627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"535364"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"566175"},{"sessionId":"11557","sessionTitle":"631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"525661"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"533973"},{"sessionId":"11558","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"528353"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"534100"},{"sessionId":"11559","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562259"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"570648"},{"sessionId":"11560","sessionTitle":"632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533640"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"561862"},{"sessionId":"11561","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"574747"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562193"},{"sessionId":"11562","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561818"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"574600"},{"sessionId":"11563","sessionTitle":"634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"500711"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562352"},{"sessionId":"11564","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562268"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562918"},{"sessionId":"11565","sessionTitle":"635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"576103"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Immune and niche dysfunction in MDS","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"565359"},{"sessionId":"11566","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Immune and niche dysfunction in MDS","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"527724"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Molecular Mechanisms of MDS","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"500975"},{"sessionId":"11567","sessionTitle":"636. Myelodysplastic Syndromes—Basic and Translational Studies: Molecular Mechanisms of MDS","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"178093"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"574694"},{"sessionId":"11568","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Predicting Drug Response Using Novel Genomic Algorithms","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"561859"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"11014"},{"sessionId":"11569","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"564096"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561803"},{"sessionId":"11570","sessionTitle":"637. Myelodysplastic Syndromes—Clinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"575934"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"530568"},{"sessionId":"11571","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"561962"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"572234"},{"sessionId":"11572","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"574787"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"480342"},{"sessionId":"11573","sessionTitle":"641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"577487"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"535368"},{"sessionId":"11574","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"565947"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562034"},{"sessionId":"11575","sessionTitle":"642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"534331"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"533412"},{"sessionId":"11576","sessionTitle":"642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561667"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"575817"},{"sessionId":"11577","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"49382"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"20155"},{"sessionId":"11578","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561881"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"533682"},{"sessionId":"11579","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"575949"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601123"},{"sessionId":"11580","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562246"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561741"},{"sessionId":"11581","sessionTitle":"652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"501405"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"24610"},{"sessionId":"11582","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"510498"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"571577"},{"sessionId":"11583","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561723"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562943"},{"sessionId":"11584","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"561674"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"546370"},{"sessionId":"11585","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562157"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"601279"},{"sessionId":"11586","sessionTitle":"701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"561668"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"126136"},{"sessionId":"11587","sessionTitle":"703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"574534"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562086"},{"sessionId":"11588","sessionTitle":"703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"533954"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"501286"},{"sessionId":"11589","sessionTitle":"711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562067"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"535376"},{"sessionId":"11590","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"539765"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"561692"},{"sessionId":"11591","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"518724"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562227"},{"sessionId":"11592","sessionTitle":"721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"533633"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"506760"},{"sessionId":"11593","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"3306"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562392"},{"sessionId":"11594","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"503964"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562392"},{"sessionId":"11595","sessionTitle":"722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"505757"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"212370"},{"sessionId":"11596","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"561890"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562086"},{"sessionId":"11597","sessionTitle":"723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"529286"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562145"},{"sessionId":"11598","sessionTitle":"731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"561755"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"508312"},{"sessionId":"11599","sessionTitle":"731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"561911"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"42253"},{"sessionId":"11600","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"585091"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"515061"},{"sessionId":"11601","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"568864"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561839"},{"sessionId":"11602","sessionTitle":"801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"532718"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"552335"},{"sessionId":"11603","sessionTitle":"801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"561931"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"561662"},{"sessionId":"11604","sessionTitle":"802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562330"},{"sessionId":"11605","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Consultative Hematology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562416"},{"sessionId":"11605","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Consultative Hematology","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"561970"},{"sessionId":"11606","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"562181"},{"sessionId":"11606","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"9:30:00 AM","sessionEndTime":"11:00:00 AM","sessionPerson":"576859"},{"sessionId":"11607","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Thrombosis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"325"},{"sessionId":"11607","sessionTitle":"901. Health Services Research—Non-Malignant Conditions: Thrombosis","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"534630"},{"sessionId":"11608","sessionTitle":"902. Health Services Research—Malignant Diseases: Pediatric and AYA Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"556662"},{"sessionId":"11608","sessionTitle":"902. Health Services Research—Malignant Diseases: Pediatric and AYA Outcomes","sessionStartTime":"7:00:00 AM","sessionEndTime":"8:30:00 AM","sessionPerson":"562353"},{"sessionId":"11609","sessionTitle":"902. Health Services Research—Malignant Diseases: Race-Ethnic and Age-Related Disparities","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"212370"},{"sessionId":"11609","sessionTitle":"902. Health Services Research—Malignant Diseases: Race-Ethnic and Age-Related Disparities","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562421"},{"sessionId":"11610","sessionTitle":"902. Health Services Research—Malignant Diseases: Adult Outcomes","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"563648"},{"sessionId":"11610","sessionTitle":"902. Health Services Research—Malignant Diseases: Adult Outcomes","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"601148"},{"sessionId":"11611","sessionTitle":"902. Health Services Research—Malignant Diseases: Innovative Predictors and Outcomes","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"499505"},{"sessionId":"11611","sessionTitle":"902. Health Services Research—Malignant Diseases: Innovative Predictors and Outcomes","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"566239"},{"sessionId":"11612","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"500745"},{"sessionId":"11612","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Sickle Cell Disease","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562395"},{"sessionId":"11613","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Health Impact and Mortality","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"601141"},{"sessionId":"11613","sessionTitle":"903. Outcomes Research—Non-Malignant Conditions: Health Impact and Mortality","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"562461"},{"sessionId":"11614","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impacting Healthcare Utilization and End of Life Care","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"247597"},{"sessionId":"11614","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impacting Healthcare Utilization and End of Life Care","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"533521"},{"sessionId":"11615","sessionTitle":"904. Outcomes Research—Malignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"511976"},{"sessionId":"11615","sessionTitle":"904. Outcomes Research—Malignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"562337"},{"sessionId":"11616","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"596383"},{"sessionId":"11616","sessionTitle":"904. Outcomes Research—Malignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"508146"},{"sessionId":"11617","sessionTitle":"904. Outcomes Research—Malignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"228952"},{"sessionId":"11617","sessionTitle":"904. Outcomes Research—Malignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"568115"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562203"},{"sessionId":"11618","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562216"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562020"},{"sessionId":"11619","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II","sessionStartTime":"12:00:00 PM","sessionEndTime":"1:30:00 PM","sessionPerson":"562289"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"569454"},{"sessionId":"11620","sessionTitle":"617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III","sessionStartTime":"2:00:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"562102"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"562151"},{"sessionId":"11622","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ","sessionStartTime":"4:00:00 PM","sessionEndTime":"5:30:00 PM","sessionPerson":"575949"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562039"},{"sessionId":"11623","sessionTitle":"651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"562248"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"599254"},{"sessionId":"11625","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation II","sessionStartTime":"6:15:00 PM","sessionEndTime":"7:45:00 PM","sessionPerson":"564289"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561830"},{"sessionId":"11626","sessionTitle":"653. Myeloma: Therapy, excluding Transplantation I","sessionStartTime":"2:45:00 PM","sessionEndTime":"4:15:00 PM","sessionPerson":"561763"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562403"},{"sessionId":"11627","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes","sessionStartTime":"10:30:00 AM","sessionEndTime":"12:00:00 PM","sessionPerson":"562404"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562451"},{"sessionId":"11628","sessionTitle":"732. Clinical Allogeneic Transplantation: Results: GVH and GVL","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"509335"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"582644"},{"sessionId":"11718","sessionTitle":"Identification of Germline Syndromes ","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:00:00 PM","sessionPerson":"590892"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","sessionStartTime":"2:00:00 PM","sessionEndTime":"2:45:00 PM","sessionPerson":"521892"},{"sessionId":"11719","sessionTitle":"Novel Aspects of Known Predisposition Syndrome","sessionStartTime":"2:00:00 PM","sessionEndTime":"2:45:00 PM","sessionPerson":"575330"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","sessionStartTime":"2:45:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"601138"},{"sessionId":"11720","sessionTitle":"Emerging New Syndromes","sessionStartTime":"2:45:00 PM","sessionEndTime":"3:30:00 PM","sessionPerson":"601139"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","sessionStartTime":"3:45:00 PM","sessionEndTime":"4:30:00 PM","sessionPerson":"580316"},{"sessionId":"11721","sessionTitle":"Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression","sessionStartTime":"3:45:00 PM","sessionEndTime":"4:30:00 PM","sessionPerson":"601140"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","sessionStartTime":"4:30:00 PM","sessionEndTime":"5:15:00 PM","sessionPerson":"589132"},{"sessionId":"11722","sessionTitle":"Reporting of Families and Variant Interpretation","sessionStartTime":"4:30:00 PM","sessionEndTime":"5:15:00 PM","sessionPerson":"534556"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"598650"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601143"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601300"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601143"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"562425"},{"sessionId":"11723","sessionTitle":"Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes","sessionStartTime":"5:15:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"601301"},{"sessionId":"11727","sessionTitle":"ASH-FDA Joint Symposium on New Drugs in Acute Myeloid Leukemia","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"574897"},{"sessionId":"11729","sessionTitle":"ASH-FDA Joint Symposium on New Drug Approvals in Acute Lymphoid Leukemia and Non-Hodgkin Lymphoma","sessionStartTime":"4:30:00 PM","sessionEndTime":"6:00:00 PM","sessionPerson":"574897"},{"sessionId":"11731","sessionTitle":"Stem Cells ","sessionStartTime":"1:05:00 PM","sessionEndTime":"1:50:00 PM","sessionPerson":"589704"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","sessionStartTime":"1:50:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601155"},{"sessionId":"11732","sessionTitle":"Signaling and Developmental Hematopoiesis ","sessionStartTime":"1:50:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601284"},{"sessionId":"11733","sessionTitle":"Myeloid Malignancies","sessionStartTime":"5:00:00 PM","sessionEndTime":"5:45:00 PM","sessionPerson":"534434"},{"sessionId":"11734","sessionTitle":"Transcription Factors/Epigenetics","sessionStartTime":"4:15:00 PM","sessionEndTime":"5:00:00 PM","sessionPerson":"575194"},{"sessionId":"11735","sessionTitle":"New Investigators ","sessionStartTime":"2:35:00 PM","sessionEndTime":"3:25:00 PM","sessionPerson":"562807"},{"sessionId":"11737","sessionTitle":"Stem Cells and Aging ","sessionStartTime":"1:05:00 PM","sessionEndTime":"2:05:00 PM","sessionPerson":"562753"},{"sessionId":"11738","sessionTitle":"Aging, Inflammation and Immune Function ","sessionStartTime":"2:20:00 PM","sessionEndTime":"3:05:00 PM","sessionPerson":"575285"},{"sessionId":"11740","sessionTitle":"Thrombosis and Aging","sessionStartTime":"3:35:00 PM","sessionEndTime":"4:20:00 PM","sessionPerson":"582147"},{"sessionId":"11741","sessionTitle":"Clinical and Biologic Correlates of Frailty in Hematology","sessionStartTime":"4:35:00 PM","sessionEndTime":"5:20:00 PM","sessionPerson":"595803"},{"sessionId":"11747","sessionTitle":"K2R Introductory Panel","sessionStartTime":"2:00:00 PM","sessionEndTime":"2:30:00 PM","sessionPerson":"53371"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"562033"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"562918"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"569684"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"601258"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"534647"},{"sessionId":"11752","sessionTitle":"Plenary Scientific Session","sessionStartTime":"2:00:00 PM","sessionEndTime":"4:00:00 PM","sessionPerson":"601259"},{"sessionId":"11902","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"585622"},{"sessionId":"11902","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"562752"},{"sessionId":"11903","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"553091"},{"sessionId":"11903","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"477980"},{"sessionId":"11906","sessionTitle":"Opening Remarks ","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:15:00 PM","sessionPerson":"573906"},{"sessionId":"11910","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"570138"},{"sessionId":"11910","sessionTitle":"Opening Remarks","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"534128"},{"sessionId":"11911","sessionTitle":"Opening Remarks ","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"565946"},{"sessionId":"11911","sessionTitle":"Opening Remarks ","sessionStartTime":"1:00:00 PM","sessionEndTime":"1:05:00 PM","sessionPerson":"573876"},{"sessionId":"11942","sessionTitle":"Featured Topic: Hemophilia Revolution","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"508870"},{"sessionId":"11942","sessionTitle":"Featured Topic: Hemophilia Revolution","sessionStartTime":"11:15:00 AM","sessionEndTime":"12:15:00 PM","sessionPerson":"559648"},{"sessionId":"11943","sessionTitle":"Featured Topic: Combination Therapies: How Are We Deciding What to Utilize?","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:15:00 PM","sessionPerson":"587668"},{"sessionId":"11943","sessionTitle":"Featured Topic: Combination Therapies: How Are We Deciding What to Utilize?","sessionStartTime":"1:15:00 PM","sessionEndTime":"2:15:00 PM","sessionPerson":"601260"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"601191"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"601193"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"587770"},{"sessionId":"12020","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:20:00 PM","sessionPerson":"570420"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"3:05:00 PM","sessionEndTime":"3:20:00 PM","sessionPerson":"601194"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"3:05:00 PM","sessionEndTime":"3:20:00 PM","sessionPerson":"601195"},{"sessionId":"12021","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"3:05:00 PM","sessionEndTime":"3:20:00 PM","sessionPerson":"585045"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"4:20:00 PM","sessionEndTime":"4:35:00 PM","sessionPerson":"582147"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"4:20:00 PM","sessionEndTime":"4:35:00 PM","sessionPerson":"599642"},{"sessionId":"12022","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"4:20:00 PM","sessionEndTime":"4:35:00 PM","sessionPerson":"587993"},{"sessionId":"12023","sessionTitle":"Closing Remarks ","sessionStartTime":"5:35:00 PM","sessionEndTime":"5:40:00 PM","sessionPerson":"562752"},{"sessionId":"12024","sessionTitle":"Hemoglobin Thresholds and Population Health ","sessionStartTime":"1:05:00 PM","sessionEndTime":"2:55:00 PM","sessionPerson":"477980"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"5:20:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"567659"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"5:20:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"566402"},{"sessionId":"12026","sessionTitle":"Panel Discussion/Questions","sessionStartTime":"5:20:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"569379"},{"sessionId":"12032","sessionTitle":"Panel Discussion","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601264"},{"sessionId":"12032","sessionTitle":"Panel Discussion","sessionStartTime":"2:05:00 PM","sessionEndTime":"2:35:00 PM","sessionPerson":"601265"},{"sessionId":"12033","sessionTitle":"Panel Discussion","sessionStartTime":"3:35:00 PM","sessionEndTime":"4:05:00 PM","sessionPerson":"561713"},{"sessionId":"12033","sessionTitle":"Panel Discussion","sessionStartTime":"3:35:00 PM","sessionEndTime":"4:05:00 PM","sessionPerson":"601271"},{"sessionId":"12034","sessionTitle":"Panel Discussion","sessionStartTime":"5:05:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"587220"},{"sessionId":"12034","sessionTitle":"Panel Discussion","sessionStartTime":"5:05:00 PM","sessionEndTime":"5:35:00 PM","sessionPerson":"589435"},{"sessionId":"12035","sessionTitle":"Closing Remarks ","sessionStartTime":"5:35:00 PM","sessionEndTime":"5:40:00 PM","sessionPerson":"565946"},{"sessionId":"12035","sessionTitle":"Closing Remarks ","sessionStartTime":"5:35:00 PM","sessionEndTime":"5:40:00 PM","sessionPerson":"573876"},{"sessionId":"12037","sessionTitle":"Late-Breaking Abstracts Session","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"533488"},{"sessionId":"12037","sessionTitle":"Late-Breaking Abstracts Session","sessionStartTime":"7:30:00 AM","sessionEndTime":"9:00:00 AM","sessionPerson":"575112"},{"sessionId":"12040","sessionTitle":"Hemoglobin Thresholds and Clinical Medicine","sessionStartTime":"3:10:00 PM","sessionEndTime":"4:30:00 PM","sessionPerson":"553091"},{"sessionId":"12041","sessionTitle":"Conclusions and Study Needs","sessionStartTime":"4:30:00 PM","sessionEndTime":"4:40:00 PM","sessionPerson":"601277"},{"sessionId":"12041","sessionTitle":"Conclusions and Study Needs","sessionStartTime":"4:30:00 PM","sessionEndTime":"4:40:00 PM","sessionPerson":"601278"},{"sessionId":"12042","sessionTitle":"Closing Remarks ","sessionStartTime":"4:40:00 PM","sessionEndTime":"4:45:00 PM","sessionPerson":"553091"},{"sessionId":"12042","sessionTitle":"Closing Remarks ","sessionStartTime":"4:40:00 PM","sessionEndTime":"4:45:00 PM","sessionPerson":"477980"},{"sessionId":"12046","sessionTitle":"NHLBI Presentation ","sessionStartTime":"3:25:00 PM","sessionEndTime":"3:35:00 PM","sessionPerson":"601298"},{"sessionId":"12047","sessionTitle":"NIDDK Presentation","sessionStartTime":"3:35:00 PM","sessionEndTime":"3:45:00 PM","sessionPerson":"601297"}]
